Frank Vinluan

PPD's new CEO Ray Hill brings global knowledge and experience that will help the CRO succeed in today's healthcare business landscape. Read more on CROs and global entrepreneurship.

Pharmaceutical companies are trying to adapt their marketing to an increasingly digital world. To get a handle on this environment, one company has appointed a digital advisory board of marketers from other industries.

Pharma reps at GSK are selling their products in a new way. The emphasis is more on communicating a drug's benefits and risks than trying to sell as much as possible. Read more about this change in approach to sales.

At-the-market offerings are used for investing in other industries, but they are just starting to pick up in life science investing. Read more on what the healthcare business should know about ATM offerings.

A new marine biotech center will be established to help companies commercialize biotech-based products originating on the North Carolina coast. The North Carolina Biotechnology Center has awarded a $2.5 million, four-year grant for the center.

Innovations receiving funding at North Carolina State University include two projects with healthcare applications: work on a new Salmonella vaccine and wound-healing bandages.

A startup company with a new way to make nanofibers sees many potential applications in the medical business. Xanofi has the technology to make strides in several industries, including the healthcare business.

A North Carolina startup is taking on the problem of counterfeit drugs. The company’s technology embeds a tiny tag into the medicine itself that allows for identification and authentication to fight fraudulent pharmaceuticals.

Hatteras Venture Partners, a venture capital firm, will invest $20 million to $30 million in helping companies through first-in-man and preclinical studies. The firm expects to invest in 10 to 15 companies in the healthcare business.

Former U.S. Senator Tom Daschle gives his viewpoint on healthcare reform legislation and the obstacles ahead. Read more to learn about the legal, administrative and regulatory challenges ahead as a result of this major legislation.